The Potential of CAR T Therapies: Q&A with Ying Huang
Legend Biotech revealed data collected from the CARTITUDE-2 Cohort D study at ASCO 2024 in Chicago in late May and early June of this year. The study is testing the ability of Carvykti to treat patients with relapsed/refractory multiple myeloma. The company’s CEO, Ying Huang, PhD, spoke with Pharmaceutical Executive about these results and their implications.
Traditional Chinese Medicine Compound Reduces Risk of Progression for Those With Prediabetes
Impaired glucose tolerance is a significant risk factor for developing diabetes.
Current State of the Pharma Sales and Marketing Sales Force
Industry experts, in a roundtable discussion, explore the evolution of brand engagement in the age of AI, including the growing importance of message relevance—and, for pharma, going where the information is.
The AI Influencer Ads Are Coming
Look closely. Is that a real person?
Talkspace announced it will join forces with FitOn to provide a holistic mental health and fitness solution to employers, and showcase the power of bringing together physical and mental fitness into an everyday setting.
Suzanne Shelley (she/her)’s piece for this month’s Pharmaceutical Commerce Magazine covers several solutions that AllazoHealth has been pioneering for years. CEO William Grambley contributed to the subject, “Combining RWE and AI to Bend the Adherence Curve.”
He shares, “Using our data-driven intelligence, we are able to drive the optimal combination of elements from the matrix that will provide the most personalized and impactful outreach for any given patient.”
For more, check out https://lnkd.in/gkxCfxst
.
.
.
#RWE #healthcareAI #medicationadherence
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs